Air pollution has emerged as an unexpected risk factor for diabetes 1-6 . The mechanisms 16 linking air pollution and diabetes remain, however, unknown. It has been postulated 17 that lung exposure mediates diabetes via systemic inflammation and insulin resistance 7-9 . 18 By contrast, gut exposure to pollutants has received little attention, even though a large 19 proportion of air pollution particles are swallowed after mucociliary clearance from the 20 upper airways 10 . Here, we identified intestinal macrophages as key mediators linking air 21 pollutants with impaired beta-cell function. Upon oral exposure to air pollution, 22 intestinal macrophages up-regulated inflammatory-and interferon-response pathways, 23 which disrupted their normal differentiation towards an anti-inflammatory/resident 24 phenotype. The resulting pro-inflammatory milieu in the gut impaired beta-cell identity 25
and function via local cytokine secretion from macrophages as genetic and 26
pharmacological macrophage or IL-1β ablation protected mice from developing air 27 pollution-induced diabetes. These data establish intestinal macrophage-derived 28 cytokines as key mediators of air pollution associated beta-cell dysfunction, thus 29 pointing towards novel therapeutic strategies. 30
Air pollution has become one of the most urgent health issues worldwide, causing 6.5 31 million premature deaths in 2015 11 . Additionally, air pollution has emerged as an unexpected 32 risk factor for diabetes in many epidemiological 1-6 and rodent studies 12,13 . This association 33 even occurs at air pollution levels well below those labelled as safe by the World Health 34 Organization 14 . However, underlying mechanisms remain poorly understood, especially as air 35 pollution particles do not seem to reach the systemic circulation 15 . To date, the lung has been 36 considered as the main target organ of air pollution. By contrast, the gut has not been 37 considered, despite the fact that the majority of pollution particles eventually reach the gut by 38 mucociliary clearance from the airways 10 . Pollutants contaminate food and water, accounting 39 for additional sources of oral exposure 16 . Underlining the clinical relevance of gut exposure, 40 air pollution has been linked to increased incidence of many gastrointestinal tract diseases, 41 such as inflammatory bowel disease, appendicitis, and irritable bowel syndrome 17 . Moreover, 42 air pollutants are known to alter gut microbiota 18, 19 , increase gut leakiness 20 , and induce gut 43 inflammation 21 . Thus, the effects of air pollution on glucose metabolism could be caused by 44 gut exposure. 45
First, we evaluated the effect of exclusive lung exposure on glucose metabolism by 46 exposing mice on standard diet or on combined high-fat diet/streptozotocin (HFD/STZ; type 2 47 diabetes model) to diesel exhaust particles (DEP), particulate matter (PM), or PBS 48 (phosphate-buffered saline; control) by intratracheal instillation (30 µg twice weekly). 49
Glucose tolerance of HFD/STZ mice intratracheally exposed to DEP or PM for 3 months did 50 not differ from the controls exposed to PBS. There were no changes in body weight, insulin, 51 and fasting glucose ( Fig. 1a ). Accordingly, mice on standard diet who were intratracheally 52 exposed to DEP or PM for 6 months did not develop impaired glucose tolerance and had no 53 changes in insulin, body weight and fasting glucose (Fig. 1b) . Macroscopically, lungs from 54 intratracheally exposed mice appeared black, confirming that pollution particles reached the 55 lungs ( Fig. 1c ). These deposits caused lung inflammation, as shown by increased frequencies 56 of monocyte-derived CD11b + macrophages and eosinophils following intratracheal exposure, 57 while frequencies of tissue-resident alveolar macrophages and conventional dendritic cells 58 (DCs) were unchanged ( Fig. 1d , Extended Data Fig. 1 ). Lung exposure did not elicit systemic 59 inflammation (TNF-α, IL-6), but blood cholesterol was elevated ( Fig. 1e ,f). 60
Hypercholesterinemia was mirrored by increased liver lipids, while liver enzymes and 61 inflammatory gene expression were mostly unchanged ( Fig. 1g , Extended Data Fig. 1 ). 62
Adipose tissue inflammation, the hallmark of tissue inflammation in metabolic disease, did 63 not develop ( Fig. 1h ). Thus, although exclusive lung exposure to pollutants causes lung 64 inflammation in mice, it does not result in systemic inflammation and diabetes. 65
Next, we assessed the role of exclusive gut exposure in mediating air pollution-66 induced diabetes. Mice on a standard diet or HFD/STZ (type 2 diabetes model) were exposed 67 to DEP, PM, or PBS by oral gavage (12 µg/day on 5 days/week). Importantly, oral and 68 intratracheal exposures were carried out in parallel and contained the same weekly dose of 60 69 µg, which is equivalent to an inhalational exposure of approximately 160 μ g/m 3 . HFD/STZ 70 mice that were orally exposed to air pollutants developed worsened glucose tolerance and 71 decreased insulin secretion from 5 weeks of exposure onwards compared to controls. The 72 body weights of mice exposed to DEP were reduced, reflecting the loss of insulin's anabolic 73 function. Fasting glucose and insulin sensitivity were unchanged ( Fig. 2a ). The mice on 74 standard diet exposed to oral air pollution also exhibited impaired glucose tolerance and 75 reduced insulin from 2-4 months onwards, while their body weight, fasting glucose, and 76 insulin sensitivity remained unchanged ( Fig. 2b ). Exposure to DEP induced more pronounced 77 effects on glycemia than PM; however, there was no dose-dependency when comparing 12 78 and 60 µg DEP daily (Extended Data Fig. 2 ). Systemic TNF-α, IL-6 and lipids were not 79 altered, but liver lipids increased similar to mice with lung exposure ( Fig. 2c -e, Extended 80 Data Fig. 3 ). Neither adipose tissue, liver, nor lung inflammation occurred with oral exposure 81 ( Fig. 2e ,f, Extended Data Fig. 3 ). Thus, exclusive gut exposure to air pollution leads to 82 diabetes in mice due to reduced insulin secretion, but not as a consequence of systemic 83 inflammation and insulin resistance. 84
We then investigated whether reduced insulin secretion is due to decreased numbers of 85 beta-cells or a functional beta-cell defect. Beta-cell mass was not reduced and the number of 86 small islets even slightly increased in mice exposed to DEP (Fig. 2g ). While insulin secretion 87 was impaired in vivo ( Fig. 2a,b ), glucose-stimulated insulin secretion from islets isolated from 88 mice exposed to DEP or PBS was comparable ex vivo ( Fig. 2h ). Reduced insulin secretion 89 was not due to impaired glucagon-like peptide-1 (GLP-1) secretion by enteroendocrine cells 90 as we found similar amounts of active GLP-1 upon oral glucose stimulation and comparable 91 glucose tolerance upon blocking GLP-1 by its receptor antagonist exendin(9-39) in mice 92 exposed to DEP and controls ( Fig. 2i ,j). Further, primary colon cultures treated with or 93 without DEP ex vivo showed similar GLP-1 secretion ( Fig. 2k ). When directly quantifying 94 gene expression of islets from mice exposed to DEP or PBS, we found up-regulation of the 95 pro-inflammatory cytokine IL-1β, while beta-cell identity markers Ins2, Foxo1, and Pdx1 96 were reduced ( Fig. 2l ). Thus, the insulin secretion defect upon DEP in vivo is not due to 97 reduced beta-cell mass, but rather due to altered beta-cell identity and function, potentially 98 through enhanced IL-1β secretion. 99
To examine the role of gut inflammation in inducing this altered islet cell phenotype, 100 we first characterized adaptive immune cells of the gut. In wild-type mice exposed to DEP, 101 intraepithelial lymphocytes and their subsets were unaffected ( Fig. 3a) . Also, lamina propria 102 T-cells, dendritic cells, and innate lymphoid cells were unchanged ( Fig. 3b-d ). To 103 conclusively assess whether the adaptive immune system is required to mediate air pollution-104 induced diabetes, we exposed Rag2-/-mice who lack adaptive immunity to DEP or PBS. The 105
Rag2-/-mice exposed to DEP developed a drastic impairment of glucose tolerance already at 106 one month of exposure ( Fig. 3e ). While oral DEP led to a loss of CCR2 -("M2"-like) anti-107 inflammatory/resident intestinal macrophages indicating a change in innate immunity in the 108 gut, there were no signs of systemic or adipose tissue inflammation ( Fig. 3e -i). In sum, 109 adaptive immunity and innate lymphoid cells are not involved in air pollution-induced 110 diabetes. 111
Subsequently, we characterized innate immune cells of the gut as potential mediators 112 of the observed islet cell phenotype. In wild-type mice exposed to DEP, a distinct loss of 113 CCR2 -("M2"-like) anti-inflammatory/resident macrophages was observed, resulting in a 114 relative increase in CCR2 + ("M1"-like) inflammatory macrophages ( Fig. 4a,b ). Consistent 115 with an inflammatory milieu in the gut invoked by DEP, gene expression of colon tissue 116 showed up-regulation of pro-inflammatory cytokines (TNF-α, KC) and macrophage markers 117 (CD68, Ly6C, Fig. 4c ). To better understand the transcriptional response to DEP, we 118 performed single-cell RNA-sequencing of intestinal macrophages. By using unbiased 119 hierarchical clustering of cells, Ccr2 + inflammatory and Ccr2anti-inflammatory/resident 120 macrophages were identified as the two main populations (the latter comprising two related 121 clusters, Fig. 4d , Extended Data Fig. 4 ). First, we corroborated the increase in abundance of 122 Ccr2 + ("M1"-like) relative to Ccr2 -("M2"-like) macrophages upon exposure to DEP ( Fig.  123 4e). Subsequently, we compared the transcriptomes of cells from mice exposed to DEP or 124 PBS, stratifying the analysis by cell clusters to correct for differential abundance. 125
Significantly up-regulated genes upon exposure to DEP were related to macrophage 126 activation and interferon regulation ( Fig. 4f , Extended Data Fig. 5 ). Gene-set enrichment 127 analysis confirmed that in mice exposed to DEP, significantly up-regulated MSigDB 128
Hallmark pathways involved inflammatory, interferon α and γ responses, as well as allograft 129 rejection ( Fig. 4g , Extended Data Fig. 6 ). Thus, the normal differentiation from CCR2 + 130 ("M1"-like) to CCR2 -("M2"-like) intestinal macrophages is disrupted upon exposure to DEP, 131 leading to a pro-inflammatory milieu in the gut wall associated with the development of 132
diabetes. 133
To establish the causal link between gut innate immunity and air pollution-induced 134 diabetes, we exposed CCR2-/-mice on standard diet to oral air pollution for up to 8 months. 135 CCR2-/-mice lack CCR2-dependent monocyte recruitment and hence CCR2 + inflammatory 136 macrophages 22,23 . Accordingly, inflammatory macrophages in the gut of these mice were 137 reduced by 99.5±0.4% and anti-inflammatory macrophages by 57.7±22.4% (Extended Data 138 Fig. 7) . In contrast to wild-type mice, there was no shift towards CCR2 + ("M1"-like) 139 inflammatory macrophages upon exposure to DEP in CCR2-/-mice, protecting them from a 140 pro-inflammatory milieu in the gut, defective insulin secretion, and diabetes ( Fig. 4c,h ). As an 141 additional macrophage depletion model, we used a standard diet containing the Colony 142 stimulating factor 1 receptor (CSF1R)-inhibitor PLX5622. CSF1R regulates the survival, 143 proliferation, differentiation, and chemotaxis of macrophages 24 . In mice treated with 144 PLX5622, intestinal macrophages were strongly reduced (inflammatory by 86.7±9.9%, anti-145 inflammatory by 92.8±3.8%, Extended Data Fig. 8 ). When orally exposed to DEP for up to 10 146 months, these mice retained low numbers of intestinal macrophages, which also prevented the 147 shift towards CCR2 + ("M1"-like) inflammatory macrophages, the insulin secretion defect, and 148 diabetes ( Fig. 4i ). In both models, dyslipidemia, systemic, adipose tissue, and liver 149 inflammation did not occur upon exposure to DEP (Extended Data Fig. 7-8 ). IL-1β-/-mice 150 that were orally exposed to DEP or PBS for up to 11 months showed a loss in CCR2 -("M2"-151 like) anti-inflammatory/resident macrophages similar to wild-type mice. However, these mice 152 did not show any impairment in glucose tolerance or an insulin secretion defect, potentially 153 through the loss of macrophage-derived IL-1β secretion ( Fig. 4j ). Accordingly, treatment with 154 a monoclonal antibody against IL-1β reversed glucose intolerance in mice exposed to diesel 155 ( Fig. 4k ). Taken together, genetic and pharmacological macrophage or IL-1β ablation 156 prevents or reverts air pollution-induced diabetes. This indicates that intestinal macrophage-157 derived cytokines are the key mediators of air pollution-induced beta-cell dysfunction. 158
In sum, long-term exposure of mice to air pollution via gavage leads to impaired 159 glucose tolerance with an inability to mount an adequate insulin response, indicative for an 160 insulin secretion defect. In contrast to our findings, previous studies using whole-body 161 inhalation chambers found impaired insulin sensitivity, potentially as lung and gut exposures 162 occur concurrently 25 . Additionally, most studies were performed in mice on HFD, which per 163 se causes systemic inflammation and insulin resistance, confounding the metabolic 164 phenotype 12,13 . Importantly, only minor amounts of inhaled particles have been detected in the 165 blood circulation 15 , rendering systemic distribution of particles unlikely. We identified 166 intestinal macrophages as the key mediators between air pollutants in the gut lumen and 167 impaired beta-cell function. Indeed, intestinal macrophages can reach into the gut lumen to 168 sample luminal contents 26 . In normal health, intestinal macrophages originate from 169 monocytes and first adopt a CCR2 + ("M1"-like) inflammatory phenotype in the gut and then 170 gradually lose their inflammatory phenotype to become CCR2 -("M2"-like) anti-171 inflammatory/resident macrophages 27,28 . Air pollutants up-regulate inflammatory-and 172 interferon-related pathways in intestinal macrophages, which interferes with their normal 173 differentiation to an anti-inflammatory/resident phenotype. The ensuing pro-inflammatory 174 milieu in the gut then impacts on beta-cell identity and function. Genetic or pharmacological 175 macrophage ablation protects mice from developing a pro-inflammatory milieu in the gut, 176 defective insulin secretion and diabetes. Protection of IL-1β-/-mice and reversal from air 177 pollution-induced diabetes by pharmacological IL-1β blocking suggests a cytokine-driven 178 disease mechanism. The link between inflammation and altered beta-cell identity and function 179 is supported by previous studies: Inflammatory cytokines lead to beta-cell dedifferentiation 29 180 and a failure to coordinate insulin secretion within islets 30 , potentially as an adaptive 181 mechanism to escape beta-cell death under stress conditions 31 . Further evidence comes from 182 studies that use anti-inflammatory approaches to improve glucose metabolism 32 . The question 183 remains whether intestinal macrophages directly traffic from the gut to pancreatic islets, 184 which would be against the current dogma, or whether inflammation disseminates to the 185 pancreas through other means such as neuronal circuits, blood circulation or lymphatic 186 vessels. In contrast to mice with defective innate immunity, mice lacking adaptive immunity 187 are not protected and even develop diabetes after shorter exposure to DEP compared to wild-188 type mice. Their increased susceptibility could be due to enhanced innate immunity as 189 previously reported 33 and is consistent with our finding of increased ratios of CCR2 + 190 inflammatory intestinal macrophages and liver inflammation in Rag2-/-mice exposed to 191 DEP. In sum, our study provides novel insights into how air pollution affects glucose 192 metabolism and represents a crucial advance towards finding better disease prevention and 193 treatment strategies, and thus having a healthier society. 194
21.
Kish Male C57BL/6N mice were obtained from Charles River Laboratories (Sulzfeld, Germany). 313 CCR2-/-, IL-1β-/-and Rag2-/-mice were bred in our facility. Mice were maintained in 314 specific pathogen-free conditions with free access to water and standard pelleted food. 
Beta-cell mass 403
For heat-induced antigen retrieval, 5 µm thick sections were boiled for 30 minutes at 93°C in 404 1x epitope retrieval solution (Biosystems). The slides were stained with the primary antibody 405 for insulin (DAKO) overnight at 4°C, washed twice in PBS (5 minutes), stained with a CD45 406 antibody (BD Pharmingen) for 2 hours at room temperature and washed twice with PBS (5 407 minutes). The secondary antibodies (Life Technologies) were applied for 2 hours at room 408 temperature, washed twice with PBS, before mounting with a fluorescence mounting media 409 (Dako). A Nikon microscope at 4x magnification acquired pictures. 410
Images were analyzed using Fiji software. Analysis was performed in a semi-automated way; 411 ilastik software (https://www.ilastik.org/) was trained twice, once to recognize pancreas area 412 excluding background and lymph nodes, and the second time to recognize islets. The masks 413 ilastik generated were used to quantify the areas with Fiji. Beta-cell mass was defined as area assembly with STAR, and to generate read count table. Default settings and parameters were 432 used, except for the version of STAR updated to 2.6.1a 36 , and the STAR parameters 433 outSAMmultNmax set to 1 and alignIntronMax set to 10,000. The reference transcriptome 434 "refdata-cellranger-mm10-3.0.0", provided by 10× Genomics and based on Ensembl release 435 93 37 , was used (available at http://cf.10xgenomics.com/supp/cell-exp/refdata-cellranger-436 mm10-3.0.0.tar.gz). 437 Samples were merged with the "cellranger aggregate" procedure without downsampling. 438
Further analysis was performed starting from the UMI counts matrix by using the dropletUtils 439 (version 1.5.4), scran (version 1.12), and scater (version 1.12) 38 Bioconductor packages, 440 following most steps illustrated in the simpleSingleCell Bioconductor workflow 39 . 441
Based on the clearly bimodal distributions observed across cells, cells were filtered out if they 442 had log 10 library sizes less than 3 (i.e., a minimum of 1,000 UMIs per library), log 10 total 443 number of features detected less than 2.5 (i.e. a minimum of 317 genes detected), or if they 444 had 0%, or more than 7% of UMI counts attributed to the mitochondrial genes 40 . Low-445 abundance genes with average log 2 counts per million reads lower than 0.002 were filtered 446 out. The resulting filtered dataset included expression values for 12,182 genes for 943 cells, 447 ranging from 189 to 334 cells per sample, for a total of 420 PBS cells, and 523 DEP cells. An 448 average of 1,336 genes was detected per cell. 449
The expression values (log-transformed UMI counts) were normalized with library size 450 factors estimated from pools of cells determined based on rank correlations cross expression 451 profiles (scran function quickCluster) 39,41 . The technical noise was assumed to follow a 452
Poisson distribution, and a mean-variance trend was fitted to the data (makeTechTrend 453 function of the scran package with default parameters). This trend was subtracted to the 454 variance of each gene to obtain the residual "biological" component of the variance. After 455 performing a principal component analysis (PCA) on the top 500 most variable genes, the 456 denoisePCA function of the scran package was used to choose the number of dimensions to 457 retain in order to denoise the expression matrix. 458
Clustering cells into putative subpopulations was done on normalized and denoised log-459 counts values by using hierarchical clustering on the Euclidean distances between cells (with 460
Ward's criterion to minimize the total variance within each cluster; package cluster version 461 2.0.9). The cell clusterswere identified by applying a dynamic tree cut (package 462 dynamicTreeCut, version 1.63-1), which resulted in 4 clusters. The R package SingleR was 463 used for reference-based annotation of the cell type of cells in our dataset 42 . We used the 464 Immunological Genome Project (ImmGen) mouse database as reference 43 , and we filtered out 465 the 31 cells not annotated as "Monocytes" or "Macrophages", as these were likely 466 contaminants. 467 Differential expression between DEP and PBS cells stratified by differentiation stage was 468 performed by using a pseudo-bulk approach 44 . The UMI counts of cells from each sample and 469 each cluster were aggregated. Cells from cluster 4 were ignored because they most likely 470 represented damaged or low-quality cells (e.g. they displayed no expression of specific 471 marker genes and had a higher fraction of reads coming from mitochondrial genes). 472 Additionally, an "overall" analysis was performed where UMI counts of all cells from each 473 sample were pooled. The resulting 16 pseudo-bulk samples were then treated as bulk RNA-474 seq samples for differential expression analysis. Genes were filtered to keep those with counts 475 per million reads sequenced values higher than 1 in at least 2 samples, and detected in at least 476 5% of the cells of the cluster considered. The package edgeR (version 3.24.3) 45 was used to 477 perform TMM normalization 46 , and to test for differential expression with the Generalized 478 Linear Model (GLM) framework. Genes with a false discovery rate (Benjamini-Hochberg 479 method) lower than 5% were considered differentially expressed. Gene set enrichment 480 analysis was performed with the function camera 47 by using the default parameter value of 481 0.01 for the correlations of genes within gene sets, on gene sets from the Hallmark 482 collection 48 of the Molecular Signature Database (MSigDB, version 6.0) 49 . We considered 483 only sets containing more than 5 genes, and gene sets with a false discovery rate lower than 484 20% were considered significant. Remaining statistical analysis on the expression dataset 485 analysis and plotting were performed with the R software package (version 3.6.0). 486 487 To pharmacologically deplete macrophages, mice were fed a diet containing the CSF1R-514 inhibitor PLX5622 (1200 ppm) or a control diet (Research Diets, New Brunswick, NJ, USA). 515 516 IL-1β antibody treatment 517 Mice were exposed to DEP or PBS by oral gavage as described above. After 4 months of 518 exposure, mice received a single injection of 10 mg/kg IL-1β antibody (01BSUR; Novartis) 519 or isotype control (anti-cyclosporin A, Novartis). Treatment with the antibody was repeated 520 after one week. From week 3 on, the mice received 5mg/kg once a week. 521 522
Statistical analysis 523
Data are expressed as mean±SEM. The unpaired Mann-Whitney U test was used for statistical 524 significance (GraphPad Prism). A p-value lower than 0.05 was considered statistically 525 significant. 526
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Extended Data Fig. 1 type mice orally exposed to DEP or PBS for 6 months (gating strategies see Extended Data 588 
